Available Until 9/29/2024
View Cart

New Approaches to Managing Acute Agitation in the Hospital Setting

ACPE Activity Number: 0204-0000-23-407-H01-P
Content Release Date: 9/29/23
Expiration Date: 9/29/24
Activity Type: Application-based   
CE Credits: 1 contact hours (0.1 CEUs)
Activity Fee: Free

Activity Overview

Acute agitation, particularly in patients with schizophrenia and bipolar disorder, occurs frequently, resulting in multiple visits to the emergency department each year. The management of acute agitation occurs in various departments throughout the hospital and health system. This educational activity will discuss currently recommended patient-centered approaches to care, which includes both nonpharmacologic and pharmacologic treatments. Guideline-recommended approaches that improve the patient experience as well as improve future interactions between patients and healthcare professionals will also be discussed.

*Please note, this activity was presented live on August 29, 2023. You can only claim credit once for this activity; live or home study.

More in this Series:

Engaging the Experts Podcast: Putting the Patient First: Updates in the Management of Acute Agitation

Expert Insight Commentary: Improving the Patient-Provider Experience in Agitation Treatment


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This educational activity is pharmacists who practice in hospitals and health systems who care for or are interested in the care of patients with acute agitation.

After participating in this CPE activity, learners should be able to:

  •          Discuss currently available nonpharmacologic and pharmacologic treatments for acute agitation.
  •          Apply guideline-recommended approaches for the assessment and management of acutely agitated patients in the hospital setting.

Koth Cassavaugh, PharmD, Activity Chair
Director of Pharmacy
Auburn Community Hospital
Auburn, New York



More information on Koth Cassavaugh
Dr. Cassavaugh is the Director of Pharmacy at Auburn Community Hospital, a 99-bed acute care hospital in the Finger Lakes region of New York State. He obtained his Bachelor of Science degree and Doctor of Pharmacy from Albany College of Pharmacy in Albany, NY. Dr. Cassavaugh has served as the Chair for Premier’s Clinical Pharmacy Practice Council. He is also a consultant to Genixus and Speaker for Bioxcel. Very active in research, presentations, publications, and teaching, Dr. Cassavaugh also works with industry and pharmacy managed focused committees. He has held management positions for 19 years in both small and large hospitals.

 

Rohini (Mona) Downs, PharmD, BCPP
Psychiatry Clinical Pharmacy Specialist
Parkland Health & Hospital System
Dallas, Texas




More information on Rohini (Mona) Downs

Dr. Downs has practiced as a Clinical Psychiatric Pharmacist for 11 years and has a passion for patient education, treating substance use disorders, and serious mental illness. She is involved in interdisciplinary resident and student teaching and multiple hospital initiatives to expand mental health access to patients with mental illness. She greatly enjoys her work, but also loves to unwind at home with her husband, 3 children, extended family, and friends, travelling, reading, and listening to true crime podcasts.


len Gard CPhT-Adv, CSPT is the national director of compounding compliance for Option Care Health and is a member of the State of Illinois Board of Pharmacy. Mr. Gard is an inaugural member of the PTCB’s CSPT exam development committee. He is an active member of ASHP having served as the chair of the Pharmacy Technician Forum Executive Committee and is a current member of the Education and Workforce Development Committee. Additionally, Mr. Gard has been an active member of NHIA and was recently appointed as Co-Chair of the Sterile Compounding Practice Committee. 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

  • The following persons in control of this activity’s content have relevant financial relationships:
    • Koth M. Cassavaugh – BioXcel: Speaker’s Bureau 

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity. All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

Activities can be completed in any order. Each activity consists of audio and video, an assessment, and an evaluation. Learners must review all content and complete an evaluation to receive continuing education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.

Provided by ASHP
Supported by an unrestricted educational grant from BioXcel